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Background: To report changes in body weight, total and central fat mass, metabolic, hormonal and inflammatory
parameters in overweight people who participated in a six months weight loss intervention associating diet
management and exercise.
Subjects and Methods: Fourteen subjects (10 M, 4 F, mean age 62.9 ± 6.9 years, BMI 30.4+/- 3.8 kg/m
2)
presenting the characteristics of the Metabolic Syndrome (MS) were included in the survey. They followed a three
weeks (D0 to D20) cure in a medical establishment and a six months (D20 to M3 and M6) follow up at home.
During the cure, they receive a balanced diet corresponding to 500 Kcal deficit vs their dayly energy expenditure
(DEE) and they exercised 2 to 3 hours per day.
At D0, D20, M3 and M6, body composition (lean mass, total and central fat mass) was analyzed with DEXA, blood
pressure was taken and blood was collected to evaluate glycaemia, triglycerides, total, LDL and HDL cholesterol,
insulin, leptin and adiponectin levels, CRP and pro-inflammatory interleukines IL1, IL.6 and TNFalpha.
Results: All parameters listed above except the cytokine were improved at D20, so that 4 subjects among 14 still
presented the MS. After returning to home, these parameters remained stable.
Conclusion: The efficacy of therapeutic lifestyle modifications with education and exercise and diet was
demonstrated, but the compliance to the new healthy lifestyle initiated during the cure was not optimal.
Introduction
Increase of body mass index (BMI) is a major risk factor
of metabolic illness [1], in relation to abdominal obesity
[2]. Visceral fat, as reflected by waist circumference, is
linked to a lot of metabolic abnormalities like impaired
glucose tolerance, dyslipidemia, high blood pressure
(BP). This metabolic profile, called metabolic syndrome
(MS), is associated with an increased risk of cardiovas-
cular diseases (CVD) and type 2 diabetes prevalence [3].
In developed countries, its prevalence is increasing and
is mainly linked to obesity and age [4].
The International Diabete Federation (IDF) has
defined MS criteria as the co-occurrence of any three of
the five following abnormalities: abdominal obesity
(waist circumference > 94 cm in men and > 80 in
women), dyslipidemia (triglyceridemia > 1,5 mmol/l,
HDL cholesterol < 0.4 g/l in men and < 0.5 g/l in
women), BP > 130/85 and/or treatment, and fasting
glycemia > 5.55 mmol/l and/or treatment [5].
MS is acknowledged as a major cardiovascular risk
factor of morbidity and mortality [6,7]. Moreover, it is
associated with other metabolic abnormalities as a
chronic systemic inflammation attested by an increase
in blood IL-1, [8], IL-6, [9] and TNF-alpha [10] and
correlated with visceral fat and insulinoresistance [11].
Physical-activity may increase systemic inflammation
[12], although some studies showed a long-term reduc-
tion [13].
Some studies relate that MS may be reduced by
change in diet habits, physical exercise and/or drug
treatment [6]. Diet changes often consist in significant
caloric intake reduction (at least 500 kcal/day). Physical-
activity generally associates endurance (low intensity)
and resistance (intensity higher than VO2max) exercises.
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ities have been studied only for short term period (few
weeks) and long-term effects remain unknown. A bad
compliance, often observed in the subjects after acute
treatment, seems responsible of treatment failure when
patients return to routine life conditions.
In this survey, we analysed the specific effects on
weight, glucido-lipidic metabolism and regulation,
inflammation and adipokines, of an intervention pro-
gram including two parts: a cure, or a three-week resi-
dential program during which they stayed in a medical
establishment, with control on diet and physical-activity,
and a six-month follow-up post-cure.
Subjects and Methods
Fourteen volunteers presenting the symptoms of the
metabolic syndrome, 10 men, 4 women, 62.9 ±
6.9 years, were enrolled by their general practitioner.
For inclusion in the study, they underwent a clinical
examination by the same physician of our group; briefly,
we used the International Diabetes Federation (IDF) cri-
teria defined in 2005 [5]. All of them should have no
medications known to affect cholesterol measures, no
medical affections contra-indicating the physical-activity
and restricting diet in the past year. All participants
completed this pilot study. This study was approved by
the local ethical “Committee for the Protection of the
Person for Research in Biology” (CPPRB).
Study Design
The study design is displayed in Figure 1. It lasted six
months and included three chronological steps: before
entering the cure (Day 0 : D0), the three-week cure (D0
to D20) and following the cure (D20 to Month 6 : M6).
Clinical, biological and body composition parameters
were assessed at D0, D20, M3 and M6.
At D0, basal metabolic rate (BMR) was calculated
using the equations of Black [14]: (Basal Metabolic








Anthropometrical and clinical values (weight, size
height, BMI, waist circumference, blood pressure), body
composition by DXA and biological parameters were
assessed. Before entering the cure, each patient com-
pleted questionnaires concerning his food intake and his
physical-activity over a week. Daily Energy Intake (DEI)
and daily energy expenditure (DEE) were estimated
from the self reported questionnaires. The food intake
questionnaires allowed us to detect possible deficiencies
of the regime.
During the three-week cure, the patients carried out
daily individually adapted physical activities with a
coach: walking (2 h), aquagym, fitness (1 h); The exer-
cise intensity was stated between 40 to 60% of the heart
rate reserve (maximal theoretical heart rate - resting
heart rate), using a heart rate recorder (Polar 4000).
They followed this program six days a week. The 7th
day they walked only. Their diet allowance was managed
by a dietician. They also followed basic lectures regard-
ing metabolic syndrome, nutrition physiology, cooking
and physical-activity. The aim of the educational accom-
paniment was to teach them the lifestyle they need to
self-manage to keep benefit of the cure after its end.
At D20, the patients came back to home and thus
became autonomous, i.e. they have to manage the pro-
gram by themselves. Thereafter, one meeting of physi-
cal-activity per week (fitness or aquagym) was organized
in order to maintain the emulation and compliance to
the program. Their physical-activity and their alimenta-
tion were recorded bimonthly by questionnaires. They
could ask a dietician and a coach if they had any ques-
tions. Clinical and psychological follow-up was evaluated
by a physician.
Daily Energy Intake, physical activity index and balance
Estimation of DEI was based on questionnaires before
and after the cure (three-day food record once every
15 days). Daily energy expenditure (DEE) was quantified
by collecting time and intensity of each physical activity
and the physical activity index (PAI = DEE/BMR) was
calculated [15]. Each day during the cure, the patients
received standardized and personalized balanced meals
as established by dieticians. The aim was to rebalance
macronutrients equilibrium as follows: 30 to 35% by
lipids, 15 to 20% by proteins and the remaining by
carbohydrates.
Daily physical activity was set for each subject in order
to obtain a physical activity index equal to 1.4 [15,16].
Cure Post-cure









Questionnaires : nutrition and physical activity Questionnaires





: After the cure, physical-activity and alimentation 
were recorded bimonthly by questionnaires
Figure 1 Study design: a three-week intervention with
standardized and personalized diet and physical activity,
followed by an autonomous period for diet and physical
activity accompanied by a weekly recall for physical activity.
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o r d e rt or e a c han e g a t i v ee n e r g yb a l a n c e( E B=D E E -
DEI) of 500 kcal at least vs usual intake.
Biometry and Anthropometry
All subjects completed medical examinations. Body
height was measured with a stadiometer, body mass was
determined using an electronic scale and BMI was cal-
culated as W/H
2 . Waist circumference and blood Pres-
sure were recorded. Body composition was assessed by
dual energy X-ray absorptiometry (DXA, Hologic QDR
Delphi series; Waltham, USA). The in vivo coefficients
of variation were 4.2 and 0.48% for fat and lean mass
respectively. Central fat, (approximation of the visceral
fat), was assessed with DXA. It consisted to measure the
% fat in a rectangle defined from the upper edge of the
second lumbar vertebra to the lower edge of the fourth
lumbar vertebra. The vertical sides of this area were the
continuation of the lateral sides of the rib cage [17]. All
measures for a given parameter were done by the same
investigator.
Biochemical Measurements
Fasting blood samples wered r a w nb e t w e e n7 . 3 0a n d
8.30 a.m. on suitable tubes, aliquoted and stored at -80°
C until analyses. Basic biology (glycaemia, blood lipids,
creatinin, CRP, alpha 1-acid glycoprotein (a1GPA),) was
assayed in the biochemistry laboratory of the University
Hospital. Renal clearance was assessed following the
Cockcroft formula [18]. All other biochemical determi-
nations were made using commercial kits, following
manufacturer recommendations, including sampling
step, allowing the best performances of coefficient of
variation (CV) and sensitivity.
Serum insulin was assayed by ELISA (Ins-ELISA, Bio-
Line, Belgium; intra-inter assay CV of 3.0-5.3%, 4.5-9.5%
and sensitivity of 4 ng/ml).
Pro-inflammatory cytokines (TNF-alpha, IL-1 and
IL-6) were assayed by ELISA with commercial kits
(AbCys SA, Paris, France).
Sensitivity, intra- and interassay CVs were respectively
3.83 pg/ml, 6.9% and 7.4%, for TNF-alpha, 1.6 pg/ml, 5.4%
and 10% for IL-1, 0.92 pg/ml, 3.4% and 5.2% for IL-6.
The adipokines leptin and adiponectin were assayed
using commercial kits (AbCys SA, Paris, France); sensi-
tivity, intra- and interassay CVs were respectively,
0.17 ng/ml, 3% and 3.2% for leptine, 4.1 ng/ml, 4% and
5.5% for adiponectine. All components were assayed in
the same batch in order to avoid inter-assay variations.
Statistical Analysis
Gaussian distribution of the data was tested by the
Kolmogorov-Smirnov test. Data are presented as mean
± Standard Error (SE). A Newman-Keuls post-hoc test
for repeated measurements was used for normally dis-
tributed data and a nonparametric Wilcoxon test for
non-normally distributed data. Relationships between
balance energy, physical activity and others data were
assessed either by Pearson correlation or by multiple
regression analysis. Significance was accepted at the p
<0.05 level. Statistical procedures were performed by
using Statview (version 5.0; SAS institute Inc, Cary,
North Carolina, USA).
Results
Descriptive characteristics of volunteers before the cure
The main parameters of MS are presented in Table 1;
they revealed elevated lipidemia, glycaemia and BP.
Usual food intake reported by questionnaires high-
lighted various food disorders. All patients had a high
lipid (44,5% ± 4.6 of DEI) and a low carbohydrate con-
sumption (39.2% ± 5.5 of DEI), with a too elevated
high/low glycaemic index ratio (34.7 ± 10.9). Mean
cholesterol consumption was 341 ± 97 mg/d and satu-
rated fatty acid represented 16.6 ± 3.2% of DEI (39.5%
of the lipid intakes). The mean DEE before the cure
was 1983 ± 228 kcal/day corresponding to a low PAI
of 1,22 ± 0.09.
Table 1 Descriptive characteristics of the subjects at
baseline: MS markers, daily energy expenditure, physical
activity index and food intakes.
Mean ± SE Minimum Maximum
Age (years) 62,9 ± 6,9 52 79
Weight (kg) 85,6 ± 10,3 62,8 106,6
MS parameters
BMI (kg/m
2) 30,4 ± 3,8 24,3 36,9
Waist circumference (cm) 105,07 ± 7,39 93 119
Blood Pressure (mmHg) 137/83 ± 11/5 120/80 155/95
Triglycerides (mmol/l) 1,68 ± 1,15 0,9 5,1
HDL (mmol/l) 1,44 ± 0,42 0,86 2,3
Glycaemia (mmol/l) 6,15 ± 1,86 4,5 11
Basal Metabolic Rate 1625,9 ± 177,8 1171,1 1927,2
Physical Activity Index 1,22 ± 0,09 1,06 1,38
Daily Energy Expenditure (kcal/
d)
1983,3 ± 228,7 1347,2 2277,2
Daily Energy Intake (kcal/d) 2072,8 ± 556,3 1562,0 2742,7
Daily Energy Intake (kcal/kg/d) 23,8 ± 6,5 16,9 31,9
Percentage of each macronutriments in the
food
% Carbohydrates 39,19 ± 5,55 34,98 47,06
of which % Fast
carboydrates
13,85 ± 5,32 5,37 23,84
% Lipids 44,53 ± 4,66 37,86 53,97
% Proteins 16,31 ± 1,5 14,05 19,18
Protein intake
(g/kg/d)
0,91 ± 0,26 0,63 1,23
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Intervention
Evolution of food intake is presented in Table 2. Evolu-
tion of energy balance and PAI are presented in Table
3. DEI decreased and DEE increased during the cure,
both significantly, resulting in a negative balance. The
physical activity index was set at 1.42 ± 0.07. The distri-
bution in macronutrients decreased for lipids and
increased for carbohydrates and proteins. The saturated
fatty acids were reduced as well as cholesterol.
Effects (Table 3 and 4)
The association of diet and physical-activity reduced sig-
nificantly the body weight, BMI, waist circumference
and systolic BP. Fifty seven percent of weight loss
accounted for fat mass. Among fat mass, central fat
decreased significantly. The rates of HDL remained
stable and triglyceridemia showed a trend to decrease
(NS). Other blood lipid parameters decreased signifi-
cantly. The high insulinemia and HOMA-IR noted
before the cure were normalized at D20. Creatininemia
Table 2 Changes in food intakes: Percentage of macro-nutriments including saturated fatty acid, food cholesterol and
protein contribution are given
D0 D20 M3 M6 p-value
% Carbohydrates 39,2 ± 5,5 48,3 ± 2,5 42,5 ± 4,6 39,1 ± 3,4 D0 vs D20, M3 : p < 0.005
% Lipids 44,5 ± 4,7 32,8 ± 2,1 38,2 ± 4,7 41,7 ± 3,6 D0 vs D20 : p < 0,0001
% Satured Fatty Acid 16,6 ± 3,2 12,9 ± 1,4 14,9 ± 1,4 15,8 ± 1,8 D0 vs D20, M3, M6 : p < 0.0001
D20 vs M3, M6 : p < 0,0001
Food cholesterol (mg/d) 341 ± 97 271 ± 30 339 ± 160 357 ± 57 D0 vs D20 : p < 0,05
% Proteins 16,3 ± 1,5 18,9 ± 0,8 19,4 ± 0,19 19,4 ± 1,3 D0 vs M3, M6 : p < 0,05
D20 vs M3, M6 : p < 0,05
Protein Intake (g/kg/d) 0,91 ± 0,26 0,85 ± 0,11 0,94 ± 0,19 0,96 ± 0,17 D0 vs M3, M6 : p < 0,05
D20 vs M3, M6 : p < 0,05
Table 3 Changes in energy balance, physical activity index, MS parameters and body composition during cure and
follow-up.
D0 D20 M3 M6 p-value
Energy Balance (kcal/d) 92 ± 521 -751 ± 147 -521 ± 304 -413 ± 304 D0 vs D20, M3 : p < 0.005
D20 vs M3, M6 : p < 0,02
Physical Activity 1,22 ± 0,09 1,42 ± 0,07 1,31 ± 1,97 1,30 ± 0,07 D0 vs D20, M3, M6 : p < 0,035
D20 vs M3, M6 : p < 0,003
Metabolic Syndrome parameters :
BMI (kg/m
2) 30,4 ± 3,8 29,6 ± 3,6 28,4 ± 2,9 28,6 ± 2,9 D0 vs D20, M3, M6 : p < 0.0001
D20 vs M3, M6 : p < 0,0001
Waist circumference
(cm)
105,07 ± 7,39 102,68 ± 7,86 99,15 ± 6,31 98,92 ± 7,44 D0 vs D20, M3, M6 : p < 0,05
D20 vs M6 : p < 0,05








Systolic BP D0 vs D20, M3 : p < 0,05 ; Diastolic BP :
NS
Triglycerides (mmol/l) 1,68 ± 1,15 1,19 ± 0,34 1,17 ± 0,40 1,27 ± 0,61 NS (p = 0,17)
HDL (mmol/l) 1,44 ± 0,42 1,49 ± 0,31 1,31 ± 0,31 1,58 ± 0,46 D20 vs M3 : p = 0,005
M3 vs M6 : p = 0,005
Glycaemia (mmol/l) 6,15 ± 1,86 6,26 ± 1,76 5,7 ± 1,97 6,28 ± 2,34 D20 vs M3 : p = 0,0409
M3 vs M6 : p = 0,0121
Body composition measured by DEXA :
Weight (kg) 85,59 ± 10,31 83,31 ± 9,90 80,08 ± 9,53 80,73 ± 10,38 D0 vs D20, M3, M6 : p < 0,0001
D20 vs M3, M6 : p < 0,0001
Lean (g) 58287 ± 7473 57323 ± 7561 56488 ± 7892 56798 ± 7991 D0 vs D20, M3, M6 : p < 0,0001
Total fat (g) 29542 ± 9752 26737 ± 9377 25524 ± 8939 26213 ± 9580 D0 vs D20, M3, M6 : p < 0,0001
Visceral fat (g) 3277 ± 1235 2839 ± 1216 2695 ± 1069 2527 ± 1005 D0 vs D20, M3, M6 : p < 0,0001
D20 vs M6 : p < 0,0001
Bone Mineral Density (g) 2421 ± 381 2447 ± 391 2416 ± 379 2456 ± 402 D0 vs M6 : p = 0,007
M3 vs M6 : p = 0,007
Fat percentage (%) 32,33 ± 7,92 30,51 ± 8,26 29,9 ± 8,15 30,24 ± 8,33 D0 vs D20, M3, M6 : p < 0,0001
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parameters didn’t change significantly.
Descriptive characteristics following the cure
Lifestyle (Table 2 and 3)
Dietetic recommendations were given every 15 days to
keep a negative energy balance. The protein contribu-
tion increased up to 0,96 ± 0.17 g/kg/d. A progressive
increase in DEI was reported jointly to a reduction in
D E E ;t h ef o o di n t a k er e d u c t i on remained significant
until M3 concerning lipids and glucids; this reduction
was not significant at M6. The patients gradually came
back to their former dietary habits with an increasing
lipid intake, a reduction of carbohydrates contribution
with an increasing high/low glycaemic index ratio.
Effects (Table 3, 4)
The weight loss and the central fat loss continued (D20
vs. M6 : p < 0.0001), as well as the reduction of BMI
and waist circumference. The insulinemia and HOMA-
IR remained at the normal value of D20. The pro-
inflammatory marker CRP decreased significantly
whereas the inflammatory cytokines IL1, IL6 and TNF
alpha didn’t change.
Descriptive assessment at six months
At M6, we recorded the following changes vs D0 : a
weight loss of 4.36 kg (p < 0.0001), a reduction of BMI
of 1.6 kg/m2 (p < 0.0001), a fall of systolic blood pres-
sure of 4.46 mmHg (NS) and 5.39 mmHg for diastolic
blood pressure (NS), a waist circumference reduction of
5.08 cm (p < 0.05), and a reduction of triglycerides of
0.364 mmol/l or 22.7% (NS), an increase in the HDL-
cholesterol of 0.144 mmol/l or 10.14% (NS). The total
cholesterol/HDL and LDL/HDL ratio remained statisti-
cally decreased at M6. The insulinemia and HOMA-IR
normalised quickly (D20) and remained stable there-
after. CRP and TNF-alpha decreased significantly. The
pro-inflamatory factors (CRP, Alpha1GPA) decreased
significantly from D0; no changes were recorded for the
inflammatory cytokines.
No significant changes were recorded for the adipo-
kines leptine and adiponectine;
Discussion
The main findings of this longitudinal study were that a
restrictive diet associated to physical-activity induced a
decrease in cardiovascular risk factors linked to MS. All
the individuals enroled responded to the criteria of the
metabolic syndrome as defined by IDF [5]. At M6, 4
patients among 14 still presented the characteristics of
MS, which means that 71% of the group had observed
positive results, and thus a good compliance to the pro-
gram, probably in relation with the 3 weeks residential
program which acted as a booster.
Table 4 Evolution of blood markers of glucid and lipid metabolisms, pro-inflammatory factors and adipokines during
cure and follow-up.
D0 D20 M3 M6 p-value
Glucidic parameters :
Insulinemia (microU/ml) 20,96 ± 24,13 5,73 ± 0,53 5,86 ± 0,68 6,15 ± 0,51 D0 vs D20, M3, M6 : p < 0,01
D20 vs M6 : p = 0,028
Glycaemia (mmol/l) 6,15 ± 1,86 6,26 ± 1,76 5,7 ± 1,97 6,28 ± 2,34 D20 vs M3 : p = 0,0409
M3 vs M6 : p = 0,0121
HOMA-IR 6,71 ± 8,86 1,62 ± 0,62 1,48 ± 0,52 1,73 ± 0,75 D0 vs D20, M3, M6 : p < 0,01
Other lipidic parameters :
Total cholesterol (mmol/l) 6,08 ± 1,46 5,07 ± 0,95 5,13 ± 1,25 5,56 ± 0,89 D0 vs D20, M3 : p = 0,001
LDL (mmol/l) 3,79 ± 1,21 3,05 ± 0,87 3,47 ± 1,25 3,43 ± 0,95 D0 vs D20 : p = 0,003
Cholesterol total/HDL 4,65 ± 2,18 3,51 ± 0,85 4,10 ± 1,24 3,83 ± 1,37 D0 vs D20. M6 : p = 0,011
LDL/HDL 2,89 ± 1,31 2,15 ± 0,75 2,82 ± 1,21 2,42 ± 1,11 D0 vs D20, M6 : p = 0,001
D20 vs M3 : p = 0,001
M3 vs M6 : p = 0,001
Pro-inflammatory factors :
CRP (mg/l) 3,92 ± 2,40 3,83 ± 3,78 3,04 ± 3,23 2,45 ± 1,62 D0 vs M6 : p = 0,0303
a1GPA (g/l) 0,84 ± 0,16 0,79 ± 0,20 0,75 ± 0,15 0,81 ± 0,16 NS (p = 0,18)
Pro-inflammatory cytokines :
IL1 (picog/ml) 2,96 ± 0,15 2,95 ± 0,16 2,87 ± 0,04 2,93 ± 0,12 NS (p = 0,33)
IL6 (picog/ml) 1,17 ± 0,34 2,95 ± 0,16 2,87 ± 0,04 2,93 ± 0,12 NS (p = 0,36)
TNFa (picog/ml) 11,06 ± 0,42 10,99 ± 0,67 10,78 ± 0,70 10,75 ± 0,51 D0 vs M6 : p = 0,0355
Adipokines :
Leptin (nanog/ml) 14,34 ± 7,73 9,57 ± 6,27 9,78 ± 8,59 11,00 ± 10,34 NS (p = 0,1)
Adiponectin (μg/ml) 12,98 ± 4,82 15,56 ± 2,28 14,75 ± 4,80 15,45 ± 3,87 NS (p = 0,13)
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there were 4 females only, all in post menopausal stage.
There was no control group in account of ethical limita-
tions. As highlighted by the questionnaires, MS was
mainly due to bad dietary habits, particularly for the
quality and to a very low level of physical activity (Table
1 and 2). The challenge of this intervention was to
reverse their bad glucido-lipidic blood constants by
modifying their lifestyle only, without any medication.
The mediterranean diet has been shown to exert a
favourable benefit/hazard ratio to reduce the cardiovas-
cular morbi-mortality associated with MS [19]. Adding
endurance exercise training to a dietary weight-
reduction program further improves parameters of MS
and body composition [20-22].
The reduction in the prevalence of MS obtained using
this natural method in our study is similar, even better,
to those using medications like rimonabant [23] (anor-
exigenic) or methformin [24] (antihyperglycaemic), in
agreement with the conclusion of the “Diabetes Preven-
tion Program” [24] without risks of adverse effects, par-
ticularly psychic disturbancies [25].
Globally, all the parameters of the MS were improved:
weight, waist circumference, total and central fat weight
were diminished at D20 and remained stable till M6
(Table 3). Systolic blood pressure followed the same
evolution.
Although we calculated a caloric deficit of 458 kcal/d
at M6, the results recorded in Table 3 show that body
weight remained stable from M3 to M6; This may be
due to an under-statement of DEI by the patients
together with an over-statement of DEE, but another
explanation is possible: it was shown by Apfelbaum that
a reduction of the energy intake with a balanced protein
intake reduced the BMR by 20%, while the active tissue
mass remained constant [26]. Such a 20% reduction in
BMR will account for 325 kcal decrease of daily allow-
ance in our group. Consequently, a reduction in DEI
taking into account a recalculation of BMR would have
been useful.
Glucidic metabolism was significantly improved by the
cure. At D0, the patient were not hyperglycaemic but
showed a tendency to insulin insensitivity (high insuline-
mia) which was reversed at D20 and remained stable till
M3 (Table 4); however insulinemia showed a slight ten-
dency to rise between M3 and M6.
This index of the MS was then significantly improved
by the intervention as previously reported in young peo-
ple [27].
Blood triglycerides, total and LDL-cholesterol
decreased at D20 and didn’t vary after; conversely, HDL
Chol was unchanged at D20 but showed an increase
between M3 and M6; this improvement must probably
be considered in account of the long term increase of
the physical activity index (Table 3) [28].
The adiopokines which levels are generally correlated,
positively for leptin and negatively for adiponectin with
the fat mass [27], didn’t change significantly, although a
significant reduction of fat mass in the subjects of this
study.
Parameters of MS were improved without changes in
chronic systemic inflammation (Table 4), as was
reported in other studies [29,30]. In fact, basal values at
D0, even high, were not out of the normal limits for
these markers. The pro-inflammatory factor CRP only
showed an improvement from D0 to M3 and M6, corre-
sponding to a cardiovascular risk [31] and MS [32]
decreases.
Conclusion
Globally, the efficacy of therapeutic lifestyle modifica-
tions with education and counselling to exercise and
diet was demonstrated, as previously reported [33]. In
our study, the three weeks residential program allowed
a rapid improvement in parameters of the MS, since 4
subjects only among 14 still presented the MS; after
returning home, although advices have been given
along the 6 months follow-up period, the MS criter-
ions didn’t continue to progress, they remained stable
only.
This is an important issue because only long-term
changes in lifestyle can reduce morbi-mortality of MS.
In the literature, several behavioural techniques have
been used to improve patients’ adherence [34]. Future
studies should investigate the way of improving long-
term compliance in the treatment of MS, in particular
the best duration of a residential program on a larger
population for allowing new lifestyle habits.
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